Learn About Pseudomonas Stutzeri Infections

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Pseudomonas Stutzeri Infections Local Doctors?
Learn about our expert tiers
Learn more
What are the Latest Advances for Pseudomonas Stutzeri Infections?
Case Report: Community-Acquired Burkholderia cepacia Pneumonia of a Patient with Pulmonary Tuberculosis.
Stenotrophomonas maltophilia Infection Associated with COVID-19: A Case Series and Literature Review.
Tired of the same old research?
Check Latest Advances
Treatment of severe multi-drug resistant Pseudomonas aeruginosa infections.
What are the latest Pseudomonas Stutzeri Infections Clinical Trials?
Molecular Detection Of Efflux Pump and Virulence Factors Genes in Pseudomonas Aeruginosa

Summary: Pseudomonas aeruginosa (PA) is a ubiquitous aerobic, non-fermentative Gram-negative rod that is widely associated with nosocomial pneumonia and can lead to severe illness with poor outcomes, particularly in critically ill people due to the ability of some strains to cause lung epithelial injury and spread into the circulation. 2 In the intensive care unit, PA infection is ranked among the top five...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase II Randomized Trial to Evaluate the Impact of Fecal Microbiota Transplantation Using the Penn Microbiome Therapy Products on Recipient and Environmental Colonization With Multidrug-Resistant Organisms

Summary: This is a randomized, open label, comparative Phase II trial being conducted to determine whether fecal microbiota transplant using Penn Microbiome Therapy (PMT) products helps standard therapy eradicate antibiotic-resistant bacteria.